Recordati

engages in the research, development, manufacture, marketing and sale of pharmaceutical drugs for the treatment of rare diseases...
Read more
Recordati CEO: Robert Koremans

CEO

Robert Koremans

CEO Approval Rating

84/100

Annual Revenue
$2.4B
Employees
4,450
Acquisitions
10

Recordati Competitors

1Zambon
2Angelini
3Famar
4ViroStatics
5Genentech
6Shire
7Ipsen
8Pierrel
9Pfizer
10Novartis

Trending Companies